CME webinar: Heart Failure and Success in Medication Optimization (recorded)

Feb. 2024Education/Webinars
This recorded webinar will educate providers on:
  • Updated classifications and definitions of heart failure per the 2022 AHA/ACC/HFSA Guidelines for Management of Heart Failure.
  • Current guidelines for directed medical therapies.
  • Practical components of initiating and uptitrating heart failure medications.
  • Case studies from Medication Optimization Clinic.

Presenters:
  • Gavin W Hickey, MD, Assistant Professor at University of Pittsburgh School of Medicine; Medical Director, VAD Program, UPMC Heart and Vascular Institute; Program Director, UPMC Advanced Heart Failure/Transplant and Pulmonary Hypertension Fellowship Program
  • Jennifer Kliner, CRNP, Supervisor, UPMC Heart and Vascular Institute, Advanced Heart Failure and Pulmonary Hypertension Program; Regional Director, Heart Failure Medication Optimization Clinics; Program Coordinator, Comprehensive Pulmonary Hypertension

Watch now

Recent Announcements

Voluntary nationwide recall: Atorvastatin (Alkem – October)

Ascend Laboratories LLC is recalling multiple lots of Atorvastatin Calcium Tablets USP. Atorvastatin is used for the treatment of high cholesterol and to reduce the risk of certain cardiovascular events, such as heart attack and stroke.
Nov. 2025Pharmacy Updates

October 2025 UPMC for You and UPMC Community HealthChoices formulary update

Effective Oct. 1, 2025, Xifaxan and Retin-A (cream, gel) will no longer be covered by UPMC for You and UPMC Community HealthChoices due to nonparticipation in the Medicaid Drug Rebate Program.
Oct. 2025Pharmacy Updates

Voluntary nationwide recall: Ocaliva (Intercept – September)

Intercept Pharmaceuticals, Inc. is voluntarily withdrawing Ocaliva® (obeticholic acid) from the market. Ocaliva is used to treat a rare liver disease called primary biliary cholangitis (PBC).
Oct. 2025Pharmacy Updates